Skip to main content
News

CMS's Oz Signals Medicare Advantage Still Needs Watching

September 25, 2026

Oz Compares Medicare Advantage to an Overgrown Garden

CMS Administrator Dr. Mehmet Oz warned on Tuesday, September 22, 2026, that Medicare Advantage is a garden "vulnerable to weeds and overgrowth," according to Healthcare Dive's report on his remarks at a Medicare Advantage industry event. CMS, the Centers for Medicare & Medicaid Services, is the federal agency that runs Medicare, Medicaid, and the Affordable Care Act marketplaces. Medicare Advantage is the private-plan alternative to traditional Medicare, in which CMS pays insurers a set amount for each enrollee to deliver Medicare-covered benefits, often bundled with extras such as dental, vision, or prescription drug coverage.

Healthcare Dive reported that Oz's comments suggest the Trump administration remains interested in tougher oversight of Medicare Advantage, even though CMS has watered down or scrapped some of its biggest proposed oversight changes for the program earlier in 2026. The outlet did not describe a specific new rule, audit, or enforcement action tied to Oz's remarks. Instead, the garden metaphor appears to function as a public signal that CMS sees ongoing risk in how the program is run, without committing to a concrete next step.

Key Takeaway

Oz's comments describe an intent to keep watching Medicare Advantage closely, not a new rule, audit, or enrollee-facing change. Current MA members and 2026 shoppers do not need to take any action based on this report alone, but it is a signal that federal scrutiny of the program is likely to continue.

Why CMS Keeps Circling Back to Medicare Advantage Oversight

Medicare Advantage has grown into the dominant way most Medicare beneficiaries get their coverage, which is part of why regulators keep returning to it. A program that large draws sustained attention from CMS, Congress, and patient advocacy groups whenever concerns surface about how plans market to seniors, manage prior authorization requests, or document the health conditions used to calculate federal payments to insurers.

According to Healthcare Dive, CMS had floated several oversight proposals for Medicare Advantage earlier in 2026 but then pulled back or dropped some of the largest ones. Oz's garden metaphor this week reads as an attempt to keep the door open to future action even after that retreat. It does not, on its own, indicate which specific practices CMS now considers "weeds," and Healthcare Dive's report did not attribute a detailed policy roadmap to his remarks.

The metaphor itself is notable coming from a physician who now leads the agency: gardens require ongoing tending, and the phrasing implies Medicare Advantage cannot simply be left alone even if its overall structure stays intact. That framing lines up with criticism patient advocates and some lawmakers have raised over the years, pointing to prior authorization denials, aggressive marketing tactics, and payment accuracy as areas warranting continued federal attention, though Healthcare Dive's report did not tie Oz's comments to any of those issues specifically.

It helps to separate what is confirmed from what remains speculation. Confirmed: Oz made the garden comment at an industry event this week, and CMS has previously scaled back some Medicare Advantage oversight proposals during 2026, per Healthcare Dive. Not confirmed: any timeline, rule number, specific plan, or enforcement target tied to this particular statement. Readers should treat the remarks as a directional signal rather than a policy announcement.

What Senior Plan Path Readers Should Watch and Do

For seniors and families evaluating Medicare Advantage coverage, this report is a reminder to stay engaged with plan details rather than a reason to change course today. Regulatory attention on the Medicare Advantage program tends to move slowly, and any resulting rule changes would go through a public comment process before taking effect. The 2026 Medicare Annual Election Period, sometimes called open enrollment, runs from October 15 through December 7, 2026. During that window, current Medicare Advantage enrollees and those on traditional Medicare can switch plans, change drug coverage, or move between Medicare Advantage and Original Medicare for coverage that starts January 1, 2027.

A few practical steps can help you prepare regardless of how federal oversight develops:

  • Read the Annual Notice of Change letter your current plan sends before the Annual Election Period. It lists changes to premiums, copays, provider networks, and covered drugs for 2027.
  • Compare plans using Medicare's official Plan Finder tool or by speaking with a licensed insurance agent who can walk through the options available in your area.
  • Ask specifically about prior authorization rules and provider network changes, two areas that have drawn regulatory attention across the Medicare Advantage industry in recent years.
  • Keep a record of any denied claims or marketing calls that felt confusing or high-pressure. That documentation is useful if you ever need to file a complaint with CMS or your State Health Insurance Assistance Program (SHIP).

What to Watch Next

Healthcare Dive's report leaves open whether Oz's comments will translate into a formal CMS proposal, a targeted audit program, or simply continued public messaging about the sector. Readers who want to track this should watch for CMS rulemaking notices in the Federal Register and continued coverage from outlets like Healthcare Dive, which first reported these remarks. Senior Plan Path will continue following how any new Medicare Advantage oversight measures could affect plan benefits, marketing practices, or prior authorization rules as the 2026 Annual Election Period approaches. In the meantime, the most useful step for readers is the same one Medicare recommends every fall: compare your options during open enrollment rather than assuming this year's plan is still the best fit.

The original report is available from Healthcare Dive.

Get free guidance →